Skip to main content
KayOnda Bayo on Muck Rack

KayOnda Bayo

As seen in: Future Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with KayOnda

Contact KayOnda, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Real-world maintenance therapy and survival outcomes for pembrolizumab plus pemetrexed and platinum for non-small-cell lung cancer in USA

|
By Himani Aggarwal, Yimei Han, Catherine Elizabeth Muehlenbein, KayOnda Bayo
| Future Medicine Verified
ImmunotherapyAhead of Print Research ArticleOpen Access Published Online: Abstract Aim: To evaluate treatment patterns and overall survival (OS) in real world metastatic non-squamous non-small-cell lung cancer (NSQ-NSCLC) patients that received pembrolizumab plus pemetrexed-platinum (pembro+pem+plat) aligned with KEYNOTE-189.
Open in Who Shared Issue with article?
See all 1 articles